Riskpilot← Back to searchSign inGet full accessDanone AB
ABActiveOrg 5562420348Gårdsvägen 14Wholesale of pharmaceutical and medical goods · NACE 4646Est. 1985102 employees
Revenue 2024
SEK 1B
-14% vs 2023
EBITDA margin
-2.5%
+40% vs 2023
Equity ratio
19.3%
Financial strength
Net profit 2024
SEK -27,6M
+14% vs 2023
| Revenue | SEK 1B | -14% |
| EBITDA | SEK -26,1M | +40% |
| Net profit | SEK -27,6M | +14% |
| Total assets | SEK 280,7M | -23% |
| Equity | SEK 54,1M | -34% |
| Employees | 102 | — |
Legal name
Danone AB
Org number
5562420348
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
24 januari 1985
Share capital
SEK 4 544 000
Employees
102 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Föremålet för bolagets verksamhet är att bedriva försäljning av sjukhusutrustning, näringsprodukter till kliniskt närings- tillförsel samt produkter i övrigt inom området för hälso- och sjukvård ävensom bedriva härmed förenlig verksamhet. Vidare ska bolaget bedriva försäljning som grossist för mejeriprodukter och växtbaserade produkter samt därmed förenlig verksamhet.
Address
Gårdsvägen 14
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 321 712 | 323 477 | 321 446 | 319 392 | 307 680 | 1 340 481 | 1 210 369 | 1 042 743 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | 6 168 | 7 000 | 8 098 | 10 761 | 9 484 | 9 581 | 7 934 | 761 853 | −43 220 | −26 119 |
| Depreciation & amort. | — | — | — | — | — | — | — | — | — | — |
| EBIT | 6 168 | 7 000 | 8 098 | 10 761 | 9 484 | 9 581 | 7 934 | 761 853 | −43 220 | −26 119 |
| Net financials | −118 | −151 | −398 | −712 | −482 | −938 | −5 | −3 390 | 2 287 | −543 |
| Profit before tax | 6 050 | 6 848 | 7 701 | 10 049 | 9 002 | 8 643 | 7 929 | 759 253 | −40 934 | −26 663 |
| Tax | −1 477 | −1 734 | −2 105 | −2 263 | −2 176 | −1 955 | −1 861 | −189 827 | 8 988 | −913 |
| Net profit | 4 573 | 5 114 | 5 596 | 7 786 | 6 826 | 6 688 | 6 068 | 569 426 | −31 946 | −27 576 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 70 711 | 64 443 | 72 933 | 88 780 | 81 396 | 86 141 | 113 658 | 1 013 963 | 364 237 | 280 671 |
| Equity | 15 693 | 8 807 | 8 627 | 13 413 | 16 339 | 16 427 | 15 807 | 623 000 | 81 629 | 54 053 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 55 018 | 55 636 | 64 306 | 75 367 | 65 057 | 69 714 | 97 735 | 390 963 | 282 608 | 226 619 |
| Total debt | 55 018 | 55 636 | 64 306 | 75 367 | 65 057 | 69 714 | 97 735 | 390 963 | 282 608 | 226 619 |
EBITDA margin
-2.5%
This company
15.8%
Market median
-116% vs market
20152024
Equity ratio
19.3%
This company
38.2%
Market median
-49% vs market
20152024
Return on equity
-51.0%
This company
18.4%
Market median
-377% vs market
20152024
Net profit margin
-2.6%
This company
8.1%
Market median
-132% vs market
20152024
Asset turnover
3.72×
This company
1.12×
Market median
+232% vs market
20152024
Debt / equity
4.19×
This company
0.62×
Market median
-576% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
LH Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
ML External Signatory | External Signatory | 2022 | — | — |
EÅ Chief Auditor | Chief Auditor | 2020 | — | — |
MD Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2024 | — | — | |
| Chairman | 2026 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2020 | — | — | |
| Board of Directors | 2026 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2023 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
CAMPAGNIE GERVAIS DANONE | Company | 78.0% | 78.0% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
CAMPAGNIE GERVAIS DANONE
Danone AB (this company)Board members of Danone AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Henrik Andreas Rejnus | Chief Executive Officer | 0 companies |
| Marie Louise Margaretha Pierre | External Signatory | 0 companies |
| Erik Åke Martin Kraft | Chief Auditor | 0 companies |
| Mette Drakenberg | Chief Executive Officer | 0 companies |
| Blagovesta Dimitrova Karemova | Board of Directors | 0 companies |
| Manu Claessens | Chairman | 0 companies |
| Tomasz Andrzej Góra | Board of Directors | 0 companies |
| Maxime Komardine | Board of Directors | 0 companies |
| Johannes van der Wulp | Chairman | 0 companies |
| Samuel James Wolfenden | Board of Directors | 0 companies |
| Ignasi Argente Arbos | Board of Directors | 0 companies |
| Richard Luiz Trechman | Chairman | 0 companies |
| Iris van den Heuvel | Board of Directors | 0 companies |
| Ignasi Arbos Argente | Chairman | 0 companies |